Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
aimed, anagreement, attributableto, broadly, build, burden, capture, Carbeau, carrier, CEO, correlation, deduction, DMI, driver, Eastern, EBCG, efficacy, ensure, evidenced, footnote, forefront, generallyto, Healthgenetic, Health®brand, Heath, implicated, Imputation, incentivized, increasingly, irregular, issuable, Jeffcoat, kind, leverage, Leveraging, MA, medicine, midst, moth, moving, NYU, OIR, Optum, outreach, payroll, PerioPredicttest, pioneer, posted, pregnancy, proactive, Provisional, regular, reply, Similarly, Simplifying, stratification, stretch, stroke, substantive, surveillance, taxation, threeguidance, timeline, toseverance, traditionally, trend, type, undermanaged, Untitled, unvested, withHorizon, write
Removed:
accelerated, acid, activate, adrenergic, alteration, anchored, animal, antagonist, anthropometric, assigned, attempt, award, bariatric, baseline, belief, Bender, bill, billion, binding, biochemical, block, blood, borrowing, boutique, broken, caloric, Canyon, careful, carriage, cartilage, cleaning, collagen, collect, combined, combining, communication, complementing, compound, compromise, concept, connective, context, convince, counseled, Craig, created, dataset, decreased, degradation, derived, destroying, deterioration, dictate, dieting, dietitian, diminished, dismutase, distributed, distributor, DMOAD, domain, dose, dosing, dramatically, DVWA, Eliot, enrolled, etiology, evaluate, evolve, excessive, executed, exhibited, extract, fatty, FDASIA, female, fewer, fill, finally, formation, Fourteen, gamma, Geisinger, generalized, genotyped, genotyping, glutathione, gum, hand, healthy, hereinafter, hip, host, housing, hyaluronic, hygiene, inclusion, initiated, initiation, Innovation, Institutional, investigate, IRB, Jenny, Kala, larger, longitudinal, losing, lost, Lurier, male, marker, mechanical, mechanism, medically, medifast, men, methylenetetrahydrofolate, MetroWest, Minnesota, mission, modulate, MTHFR, multifactorial, MWM, narrowing, negotiate, nondiabetic, Obama, OIVD, optimization, OralDNA, painful, paraoxonase, participated, percent, peroxisome, plasma, pocket, PPAR, predictor, preliminary, premenopausal, prevalence, prime, progressed, proinflammatory, promising, protocol, PST, Quest, radiographic, Ranch, randomly, range, reactive, real, receiving, recruit, Recruitment, reductase, reflecting, reliably, relief, repair, residence, resignation, reviewing, rheumatologist, routine, scanning, selecting, separation, setting, show, sixty, specialty, statistically, subchondral, subset, sufficiently, suited, superoxide, surgery, surgical, synovial, Taxpayer, teeth, terminable, therapy, Thurston, transcobalamin, transient, transition, travel, typical, undergoing, understandable, unused, vacancy, version, worldwide, yielding
Filing tables
Filing exhibits
ILIU similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 16, 2016, with respect to the financial statements included in the Annual Report of Interleukin Genetics, Inc. on Form 10-K for the year ended December 31, 2015. We hereby consent to the incorporation by reference of said report in the Registration Statements of Interleukin Genetics, Inc. on Form S-3 (Nos. 333-163987, 333-83631, 333-53558, 333-56558, 333-101088 and 333-107782) and on Form S-8 (Nos. 333-47343, 333-67147, 333-32538, 333-62638, 333-118551, 333-176270, 333-184946, 333-190627 and 333-208094).
/s/ Grant Thornton LLP
Boston, Massachusetts
March 16, 2016